Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.39 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | KCNN4 | O15554 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12814413 | 0.82 | KCNN4 (0.34) | MAPK1ALDH1A1KCNN4 | |
| SCHEMBL12814658 | 0.81 | MAPK1 (0.32) | CYP2B6MAPK1ALDH1A1TAAR1ALOX15 | |
| Hydrochloric Acid SCHEMBL16457764 | 0.80 | ESR1 (0.40) | ESR1ESR2CYP2B6MAPK1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL16458099 | 0.80 | ESR1 (0.36) | ESR1ESR2CYP2B6MAPK1 | |
| Hydrochloric Acid SCHEMBL4978876 | 0.78 | — | — | |
| SCHEMBL16459308 | 0.71 | ESR1 (0.41) | ESR1ESR2CYP2B6MAPK1ALDH1A1 | |
| SCHEMBL12814833 | 0.69 | ESR1 (0.39) | ESR1ESR2CYP2B6MAPK1ALDH1A1 | |
| SCHEMBL8335012 | 0.68 | ESR1 (0.70) | ESR1ESR2CYP2B6MAPK1ALDH1A1 | |
| SCHEMBL430941 | 0.68 | ESR1 (0.70) | ESR1ESR2CYP2B6MAPK1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL16458789 | 0.68 | ESR1 (0.39) | ESR1ESR2CYP2B6MAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2691357-A1 | METHOD FOR PRODUCING 1-HEXENE | Sumitomo Chemical Company Limited (JP) | 2014-02-05 | — | — | EP | disclosed |
| US-20140012056-A1 | METHOD FOR PRODUCING 1-HEXENE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-01-09 | — | — | US | disclosed |
| WO-2012133937-A1 | METHOD FOR PRODUCING 1-HEXENE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-10-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140012056-A1 | METHOD FOR PRODUCING 1-HEXENE | AP2A1, AP1M1, ME1 | ESR1 452/4885ESR2 641/4885CYP2B6 150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.